Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 23, 2017
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - September 23, 2017

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

8/24/17 - Gainers & Losers Of Aug.23: ITCI, PRTK, MBIO, RARE, OVID...
In May of this year, the Company met with the FDA and sought guidance on the acceptability of the two positive clinical trials as the basis for the submission of a new drug application for the treatment of schizophrenia. That time, the FDA requested additional information to confirm that the findings observed in nonclinical animal toxicology studie
8/24/17 - Global Life Sciences BPO Market Fueled by Growing Demand for Contract Research Organizations
Life Sciences BPO Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015- 2023 Albany, NY 08/23/2017 The life sciences BPO market comprises services offered by CMOs and CROs to the biotech pharmaceutical companies. A rise in demand for low cost drugs, patent expirations and uncertain economic conditions have compelle
8/24/17 - NCLT ORDERS INSOLVENCY ACTION AGAINST ORCHID PHARMA
The National Company Law Tribunal has ordered insolvency proceedings against Orchid Pharma Ltd of Chennai. Lakshmi Vilas Bank has filed a petition with NCLT against Orchid which had availed a loan. The company is exploring suitable legal recourse, including an appeal before the National Company Law Appellate Tribunal.
8/24/17 - Recombinant Therapeutic Antibodies & Proteins Market Research Report by Key Players Analysis 2023
Transparency Market Research Report Added " Recombinant Therapeutic Antibodies& Proteins Market" to its database.Albany, NY 08/23/2017 Human proteins obtained through genetic engineering rather than from tissue samples have played a vital role in therapeutic medicines market. Advances in pharmacological understanding and pharmaceutical...
8/24/17 - Virus C treatment drugs register sales worth LE58.8m in H1 2017 [Arab Finance (Egypt)]
Five companies only, Global Napi, Mash Premiere For Pharmaceutical Industry, Pharmed Healthcare, Marker Pharma, and Gilead, accounted for 91% of total sales of the drugs, equivalent to EGP 53.6 m. In third place was Pharmed Healthcare, which registered sales of EGP 7. 2%, down by 64% from last year. Meanwhile, Pharco Pharmaceuticals, with sales of
8/23/17 - "Compositions and Methods for Treatment with Hemopexin" in Patent Application Approval Process (USPTO 20170218035)
By a News Reporter-Staff News Editor at Biotech Week A patent application by the inventors MCLEAN, Kirk; HERMISTON, Terry; BROOKS, Alan; FELDMAN, Richard, filed on September 29, 2015, was made available online on August 10, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is as
8/23/17 - "Stabilized Pharmaceutical Sub-Micron Suspensions and Methods of Forming Same" in Patent Application Approval Process (USPTO 20170216228)
By a News Reporter-Staff News Editor at Biotech Week A patent application by the inventors Asgharian, Bahram; Castillo, Ernesto J.; Chowhan, Masood A., filed on April 21, 2017, was made available online on August 10, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been
8/23/17 - 2017 Forecast Big Data In The Healthcare & Pharmaceutical Global Market Features, Grow Pricing and Revenue to 2030
Report Bazzar estimates that Big Data investments in the healthcare and pharmaceutical industry will account for nearly $4 Billion in 2017 alone.. NEW YORK, NEW YORK, UNITED STATES, August 23, 2017/ EINPresswire.com/ Big Data originally emerged as a term to describe datasets whose size is beyond the ability of traditional databases to captu
8/23/17 - 22nd Century Technology is a Game Changer
22nd Century Group, Inc., a plant biotechnology company that is focused on tobacco harm reduction, announced today that a growing number of independent scientists specializing in tobacco harm reduction are publicly proclaiming that the FDA s recently announced plan to reduce nicotine to non-addictive levels in cigarettes will drastically improve
8/23/17 - ABPI ISsues Statement on Latest Brexit Position Paper
The Association of the British Pharmaceutical Industry and the BioIndustry Association have welcomed the publication of "Continuity in the availability of goods for the EU and the UK", published today by the UK Government's Department for Exiting the European Union. aEuros aEuros aEuros aEuros The paper outlines a range of principles "to ensure tha
8/23/17 - Acting Manhattan U.S. Attorney Announces $13.4 Million Settlement Of Civil Healthcare Fraud Lawsuit Against US Bioservices Corp.
Joon H. Kim, the Acting United States Attorney for the Southern District of New York, and Scott J. Lampert, Special Agent in Charge of the U.S. Department of Health and Human Services' Office of Inspector General for the New York Region, announced that the United States has settled a civil fraud case against US BIOSERVICES CORP. pursuant to which U
8/23/17 - Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Additional Criteria and Procedures...
All comments should be identified with the OMB control number 0910-0688. Also include the FDA docket number found in brackets in the heading of this document. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. Specifically, FDA regulations
8/23/17 - Agile Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
Release date- 23082017- PRINCETON, N.J.- Agile Therapeutics Inc. a women's health specialty pharmaceutical company, announced today that Al Altomari, Chairman and CEO will present at the Rodman& Renshaw 19th Annual Global Investment Conference on Tuesday, September 12, 2017 at 9:10 AM ET in New York. To access the live and archived webcasts of the
8/23/17 - Alexion and Sema4 Partner in Rare Disease Diagnostics and Systems Biology
By a News Reporter-Staff News Editor at Biotech Week Alexion Pharmaceuticals, Inc. and Sema4 announced a strategic partnership to leverage their shared experience in data science and systems biology to accelerate rare disease diagnosis and therapeutic discovery. "The world-class sequencing capabilities at Sema4 coupled with Alexion' s SmartPanel
8/23/17 - Alexion`s (ALXN) Soliris` Label Expansion Approved in Europe [Arab Times (Kuwait)]
ALXN announced that the European Commission approved a label expansion of lead drug Soliris. The European Commission expanded the indication for Soliris to include the treatment of refractory generalized myasthenia gravis in adults who are anti-acetylcholine receptor antibody-positive. The FDA accepted the supplemental Biologics License...
8/23/17 - Alliance Foundation Trials Opens Global Trial Investigating First-in-Class Palbociclib in HR+, HER2+ Metastatic Breast Cancer
Pfizer, a pharmaceutical company, issued the following news release:. The Alliance Foundation Trials, LLC, in conjunction with Pfizer and six international cancer research groups, today announced the launch of PATINA- a randomized, open-label, Phase 3 clinical study of the cyclin-dependent kinase 4/ 6 inhibitor palbociclib. "Our partnership with t
8/23/17 - amcure Announces Formation of Inaugural Scientific Advisory Board
EGGENSTEIN-LEOPOLDSHAFEN, Germany amcure, a biopharmaceutical company developing first-in-class cancer therapeutics, today announced the appointment of a distinguished group of oncology specialists and academic leaders to the company s Scientific Advisory Board. The newly formed SAB will also provide counsel to the company as it continues to
8/23/17 - Amgen Ventures Invests in GNS Healthcare to Advance Applications of its REFS? Causal Machine Learning and Simulation AI Platforms
GNS Healthcare, a leading precision medicine company, today announced that it has raised an additional $6 million in equity from Amgen Ventures with participation from existing investor Alexandria Real Estate Equities. With this investment, Amgen Ventures joins other leading biopharma companies Celgene and Zambon Pharmaceuticals, leading health p
8/23/17 - ANGIOSOMA, INC. - 10-Q/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
AngioSoma is a clinical stage biotechnology company focused on improving the effectiveness of current standard-of-care treatments, especially related to endovascular interventions in the treatment of peripheral artery disease. Nine Months Ended June 30, 2017 Compared to the Period from Inception through June 30, 2016. We recognized general and...
8/23/17 - Argentum Pharmaceuticals and Eli Lilly Settle Patent Dispute Over CIALIS
Argentum Pharmaceuticals LLC, a generic pharmaceutical company, announced that it has reached a settlement and license agreement with Eli Lilly and Company related to Argentum's generic version of CIALIS . The agreement generally provides that Argentum may commence marketing its generic product no earlier than September 27, 2018.
8/23/17 - argenx announces publication in Nature Medicine of preclinical data supporting the therapeutic potential of SIMPLE AntibodyTM ARGX-116 for the treatment of dyslipidemia
Breda, the Netherlands/ Ghent, Belgium- argenx, a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, today announced the publication in Nature Medicine of preclinical data on ARGX-116 inhibiting ApoC3, a metabolic target correlated wi
8/23/17 - argenx announces publication in Nature Medicine of preclinical data supporting the therapeutic potential of SIMPLE AntibodyTM ARGX116 for the treatment of dyslipidemia
Release date- 23082017- Breda, the Netherlands Ghent, Belgium- argenx, a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody based therapies for the treatment of severe autoimmune diseases and cancer, today announced the publication in Nature Medicine of preclinical data on ARGX-116 inhibiting ApoC3, a metabol
8/23/17 - AROUND DELAWARE
WILMINGTON- The Medicaid Fraud Control Unit of the Delaware Department of Justice will join the United States and other states to settle allegations against Mylan Inc. and its wholly-owned subsidiary, Mylan Specialty L.P.. As part of the settlement, Delaware will receive $899,882 in restitution and other recovery, which will be returned to the Dela
8/23/17 - Asterias Biotherapeutics Gets Additional Clinical Site for Study
Asterias Biotherapeutics announced the addition of the Washington University School of Medicine in St. Louis as a clinical site in the company s ongoing SCiStar Phase 1/ 2 a clinical trial of AST-OPC1. Washington University and its partner Barnes-Jewish Hospital have one of the largest clinical spine care practices in the United States.
8/23/17 - Asterias Biotherapeutics Opens Additional Clinical Site for AST-OPC1 SCiStar Study
Asterias Biotherapeutics, Inc., a biotechnology company pioneering the field of regenerative medicine, today announced that Washington University School of Medicine in St. Louis, MO, has been added as a clinical site in the company s ongoing SCiStar Phase 1/ 2 a clinical trial of AST-OPC1, a stem-cell derived investigational therapy, in patien
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415